Alterity Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	33.16	12.64	15.77	34.81	28.12
Short-Term Investments	7.5	-	-	-	-
Cash & Short-Term Investments	40.66	12.64	15.77	34.81	28.12
Cash Growth	221.70%	-19.87%	-54.68%	23.80%	205.71%
Accounts Receivable	3.93	4.02	8.65	4.67	4.13
Other Receivables	0.01	0.02	0.02	0.06	0.15
Receivables	3.94	4.04	8.67	4.73	4.28
Prepaid Expenses	1.23	2.32	2.57	1.6	1.09
Other Current Assets	0.04	0.04	0.04	0.01	0.01
Total Current Assets	45.87	19.04	27.05	41.14	33.49
Property, Plant & Equipment	0.16	0.19	0.27	0.22	0.1
Total Assets	46.03	19.22	27.32	41.36	33.59
Accounts Payable	0.54	0.58	1.72	2.66	1.45
Accrued Expenses	2.89	4.56	2.5	3.02	1.56
Current Portion of Leases	0.07	0.11	0.11	0.06	0.03
Current Income Taxes Payable	0.02	0.02	0.03	0.03	-
Other Current Liabilities	0.02	0.11	0.03	0.06	0.03
Total Current Liabilities	3.53	5.37	4.38	5.82	3.07
Long-Term Leases	0.09	0.05	0.1	0.06	0.04
Other Long-Term Liabilities	-	-	0.02	0.01	0.01
Total Liabilities	3.62	5.43	4.5	5.89	3.12
Common Stock	262.95	223.15	213.97	213.79	197.45
Retained Earnings	-225.89	-214.16	-195.13	-181.88	-169.73
Comprehensive Income & Other	5.34	4.81	3.97	3.57	2.75
Shareholders' Equity	42.4	13.8	22.81	35.47	30.47
Total Liabilities & Equity	46.03	19.22	27.32	41.36	33.59
Total Debt	0.16	0.16	0.21	0.12	0.07
Net Cash (Debt)	40.5	12.48	15.56	34.69	28.05
Net Cash Growth	224.55%	-19.81%	-55.13%	23.67%	206.12%
Net Cash Per Share	0.01	0.00	0.01	0.01	0.02
Filing Date Shares Outstanding	9,209	5,320	2,440	2,407	2,407
Total Common Shares Outstanding	9,127	5,245	2,440	2,407	2,084
Working Capital	42.34	13.66	22.67	35.32	30.42
Book Value Per Share	0.00	0.00	0.01	0.01	0.01
Tangible Book Value	42.4	13.8	22.81	35.47	30.47
Tangible Book Value Per Share	0.00	0.00	0.01	0.01	0.01

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q